Yang Xi, Song Yueming, Liu Limin, Kong Qingquan, Gong Quan, Zeng Jiancheng, Li Tao, Tu Chongqi
Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China. Email:
Zhonghua Wai Ke Za Zhi. 2014 Jan;52(1):20-4.
To evaluate the mid-term effectiveness of nano-hydroxyapatite/polyamide66 (n-HA/PA66) cage in the anterior spinal reconstruction.
There were 177 patients who undergone the anterior decompression and fusion with n-HA/PA66 cage and internal fixation between January 2008 and January 2010 included in this study. There were 117 male and 60 female patients aged from 18 to 74 years. The diagnoses included cervical fracture in 47 patients, thoracic or lumbar fracture in 50 patients, cervical spondylopathy in 58 patients, spinal tuberculosis in 17 patients and spinal tumor in 5 patients. The X-ray and three-dimensional CT were followed up in all these patients to observe the spinal alignment, the rate of fusion and the rate of n-HA/PA66 cage subsidence and translocation. The neurological functions of patients with spinal fracture were evaluated by Frankel grading; the improvement of the clinical symptoms of the other patients were assessed by visual analogue scale (VAS) scores and Japan Orthopaedic Association (JOA) scores or SF-36 scores.
All the 177 patients had been followed-up for 36 to 70 months after surgery (average 51 months). Except the slight cage translocation been found in the only one patient with cervical fracture, no cage prolapsed or breakage was exist in our patients up to the last follow-up. In the patients with spinal fracture, the mean time for fusion was 4.5 months, the rate of fusion was 95.9% and the rate of cage subsidence was 5.2%; while in the patients with cervical spondylopathy, the mean time for fusion was 4.4 months, the fusion rate was 96.5% and the subsidence rate was 5.2%; while in patients with spinal tuberculosis, the mean fusion time was 5.5 months, the rate of fusion was 94.0%, the rate of subsidence was 5.9%; and in the patients with tumor, the mean time for fusion was 6.0 months, the fusion rate was 100%, and the cage subsidence was found in only one patient. The preoperative symptoms of each patient were improved to varying degrees after surgery. At the last follow-up, the Frankel grading of patients of spinal fracture with incomplete paralysis improved 0 to 2 classes; the VAS, JOA or SF-36 scores of the other patients were improved significantly than their respective scores before surgery (t = 2.982, 4.126 and 3.980, P < 0.05).
The n-HA/PA66 cage has much higher rate of osseous fusion and lower cage subsidence, it is an ideal cage which can provide effective restoring and maintaining for the spinal alignment and intervertebral height. Moreover, the mid-term clinical results of anterior reconstruction with this cage in the patients with spinal trauma, degeneration, tuberculosis or tumor are well content.
评估纳米羟基磷灰石/聚酰胺66(n-HA/PA66)椎间融合器在前路脊柱重建中的中期疗效。
本研究纳入2008年1月至2010年1月期间行前路减压、n-HA/PA66椎间融合器融合及内固定术的177例患者。其中男性117例,女性60例,年龄18至74岁。诊断包括颈椎骨折47例、胸腰椎骨折50例、颈椎病58例、脊柱结核17例、脊柱肿瘤5例。对所有患者进行X线及三维CT随访,观察脊柱排列、融合率、n-HA/PA66椎间融合器下沉及移位情况。对脊柱骨折患者的神经功能采用Frankel分级评估;对其他患者的临床症状改善情况采用视觉模拟评分(VAS)、日本骨科协会(JOA)评分或SF-36评分进行评估。
177例患者术后均获36至70个月(平均51个月)随访。除1例颈椎骨折患者出现轻微椎间融合器移位外,至末次随访时患者未出现椎间融合器脱出或断裂。脊柱骨折患者平均融合时间为4.5个月,融合率为95.9%,椎间融合器下沉率为5.2%;颈椎病患者平均融合时间为4.4个月,融合率为96.5%,下沉率为5.2%;脊柱结核患者平均融合时间为5.5个月,融合率为94.0%,下沉率为5.9%;肿瘤患者平均融合时间为6.0个月,融合率为100%,仅1例患者出现椎间融合器下沉。术后各患者术前症状均有不同程度改善。末次随访时,不完全性瘫痪的脊柱骨折患者Frankel分级提高0至2级;其他患者的VAS、JOA或SF-36评分较术前均显著提高(t = 2.982、4.126和3.980,P < 0.05)。
n-HA/PA66椎间融合器具有较高的骨融合率和较低的椎间融合器下沉率,是一种能有效恢复和维持脊柱排列及椎间高度的理想椎间融合器。此外,应用该椎间融合器对脊柱创伤、退变、结核或肿瘤患者进行前路重建的中期临床效果良好。